Document is current
Any future updates will be listed below
-
Authors
Boardman, Felicity https://orcid.org/0000-0002-3268-6276
Howitt, Rebecca https://orcid.org/0009-0002-5743-0725
Young, Philip
Clark, Corinna https://orcid.org/0000-0002-1077-9383
- License Information
-
More Information
Article History
Received: 14 February 2026
Revised: 18 March 2026
Accepted: 24 March 2026
First Online: 9 April 2026
Competing interests
: FB sits on the Foetal, Maternal and Child Health Reference Group of the UK National Screening Committee. No other authors have conflicts to declare. Novartis Gene Therapies had no input into the study design, data collection instruments, data analysis, interpretation or findings of this study.
: Informed consent was obtained from all participants. Approval for data collection with the public, HCPs and SMA families was granted 18/11/22 by the Biomedical and Scientific Research Ethics Committee, University of Warwick. Approval for data collection with families offered screening through the Thames Valley Pilot Study was granted by the Health Research Authority through NHS REC 21/SC/0394 on 15/8/23.
